← Back to Search

Secondhand Cannabis Smoke Exposure for Healthy Subjects (CAN03 Trial)

N/A

Waitlist Available

Led By Suzaynn F Schick

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (before exposure) and the morning after exposure, up to 22 hours.

Awards & highlights

CAN03 Trial Summary

This trial studied the effects of secondhand cannabis smoke on healthy people who don't smoke.

Who is the study for?

This trial is for healthy adult nonsmokers aged 21-50 with normal blood pressure and BMI, who don't use cannabis or tobacco products, aren't exposed to smoke in their jobs, and have no major health issues like heart disease or diabetes. Pregnant women and those with a history of drug abuse or certain psychiatric conditions cannot participate.Check my eligibility

What is being tested?

The study investigates the effects of secondhand cannabis smoke on healthy individuals. Participants will be exposed to this environment without any blinding as part of a pilot study to measure pollutants and exposures from the smoke.See study design

What are the potential side effects?

Since this is an observational study about environmental exposure rather than a drug trial, direct side effects are not expected from interventions. However, participants may experience irritation from secondhand smoke.

CAN03 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (before exposure) and the morning after exposure, up to 22 hours.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (before exposure) and the morning after exposure, up to 22 hours.

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (before exposure) and the morning after exposure, up to 22 hours. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in the concentration of urinary cannabinoid metabolites in health nonsmokers exposed to cannabis smoke and emissions

CAN03 Trial Design

1Treatment groups

Experimental Treatment

Group I: Exposure to secondhand cannabis smoke in public placesExperimental Treatment1 Intervention

The research staff and participants will travel together to a public location by either ride share vehicles, taxis or public transit. The study will arrange and pay for the transit. Staff and participants will be exposed to ambient air in public places where cannabis products are being consumed by smoking, vaporizing or dabbing. Participants will remain in the company of the laboratory staff throughout the exposure. The exposures will last 0.5-4 hours, depending on the nature and duration of the event. Staff and participants will travel together back to the laboratory for the post-exposure study measures.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor

2,507 Previous Clinical Trials

15,238,375 Total Patients Enrolled

Suzaynn F SchickPrincipal InvestigatorUniversity of California, San Francisco

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial have an age limit, and if so can participants over 60 years old take part?

"According to the criteria for participation, only persons aged between 21 and 50 are eligible for enrollment in this trial."

Answered by AI

What criteria is necessary to be eligible for this clinical trial?

"Patients between 21 and 50 years old are eligible to be enrolled in this clinical trial, which is looking for 200 healthy individuals."

Answered by AI

Are there any available openings to join this clinical trial?

"While the clinical trial was initially posted in September of 2023, there is no indication that it is presently seeking participants. However, per the data on clinicaltrials.gov, 918 other trials are actively enrolling patients at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Measuring Environmental Tobacco and Cannabis: Pollutants and Exposures

2023. "Measuring Environmental Tobacco and Cannabis: Pollutants and Exposures". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06030674.